Hepatitis C Support Group
Hepatitis C is a blood-borne viral disease which can cause liver inflammation, fibrosis, cirrhosis and liver cancer. The hepatitis C virus (HCV) is spread by blood-to-blood contact with an infected person's blood. Many people with HCV infection have no symptoms and are unaware of the need to seek treatment. Hepatitis C infects an estimated 150-200 million people worldwide.
Who can afford that. If they priced it more reasonable they would move much more product and make even more profits.
It's just bad business and competition will move ahead.
Drugs are not free in Canada. You need a private health plan or you have to pay!
I had to pay for my own Interferon/Riba out of pocket ..OUCH ..no cure, serious damage, very expensive and still HCV pos ..
(not bitter at all ..lol)
I have nothing good to say about Gilead, except the drugs do work.
I have a feeling the BoD at Gilead will be loosing more than a little sleep over this. At least I hope they do!
My chances of off-label Sovaldi and Olysio are pretty much dead in the water at this point. My doctor felt so confident he could get it through - but that was two months ago - before Express Scripts took this stance against the price. However, ES is a HUGE pharma provider, so yep, a lot of pressure is headed toward Gilead. I'm just thankful I can wait a while - not too long since I'm well compensated - but this is a tragedy for those with Express Scripts who needed to treat as soon as a non-interferon tx was FDA approved.
I don't know. I don't have that.
But Medicare PART D is their pharma program.
Medicare is for doctor visits, labs, procedures, etc.
You or your doctor can call and ask your PHARMA provider if they are covering Sovaldi.
I called Express Scripts - and was told NO, they are not carrying Sovaldi.
1) There are a total of 6.28M people with HCV in the US - and many of those don't even know that they are infected.
2) Assume 50% will treat with new drug = 3.14M
3) Assume out of the 3.14M, 50% pay full rate of $84K and 50% pay 50% ($42K), on average.
4) 50% of 3.14M = 1.57M.
5) 1.57M paying full price generates $131.9B.
6) 1.57M paying 50% generates $65.9B
7) Total MAX generated: $197.8B.
8) Gilead paid $11B to Pharmasset and conducted several more years of costly R&D.
9) Total cost: assume $22B (initial outlay + follow-up R&D).
10) Earnings before taxes, interest depreciation and amortization = $175.8B ($197.8 - 22).
11) Assume tax rate of 35%. Taxes = $61.5B
12) After tax profit = $114.3B (assume interest, depreciation and amortization = 14.3B).
13) Total US Profit = $100B.
So this is the BEST case scenario in the US if 50% of folks jump on immediately. They'll make about $100 billion, max. That's it unless the other 3.14M jump in. There are only 17K new cases of HCV reported in US each year so the 6.28M is their entire target market.
There's an estimated 120M people infected with HCV world wide. Of course Gilead will be expected to dispense these drugs to 2nd and 3rd world countries at little or no cost to them. We in the first world pay for that via our high price tag. But with the hefty $100B profit in their pocket, they shouldn't squawk too much.
Is all this too high? Well, I don't see any non-profits jumping in to develop anything. Profit motivates companies. The USA has the best (and alas, most prolific) pharma machine in the world. If it weren't for the US leading the way, where would we all get our new HCV drugs?
I was cured on Gilead's nickel (via a trial) and was glad of it. However, in 2011 my insurance company paid $72K to Vertex and Genetech for 12 agonizing week's of triple treatment drugs that FAILED.
However, this time around, if my insurance company didn't pay for Gilead's new drug, then with the new health care law, I'd go buy a more expensive insurance that would pay (as pre-existing is now a thing of the past - God I hope so!).
Gilead bashing is popular on this forum, but I for one am glad they developed the drugs and I would've found a way to pay for it if necessary.
Because being cured is a wonderful thing!
Thanks Gilead...
HC
So these things can be complicated.
Hepcat - there is NO WAY I can "find a way" to pay for Sovaldi. As if I could borrow that kind of money. And I don't have rich, generous relatives. For MANY of us, there is just no way to pay for this stuff out of our own pockets. The "assistance" Gilead is offering is something I don't qualify for because I have a federal healthcare program - TriCare - it's in the "fine print" of the Gilead "assistance" verbiage.
So - hey - I give up for now. I'm going to have to wait for Abbvie and hope Express Scripts will pay for THAT - and there is no guarantee.